Search Results
Kaylee B Punter
Kaylee B Punter
Department of Biomedical and Medical Sciences, Queen’s University, Kingston, Canada
Search for other papers by Kaylee B Punter in
Google Scholar
PubMed
Search for other papers by Kaylee B Punter in
Google Scholar
PubMed
Charles Chu
Charles Chu
Department of Biomedical and Medical Sciences, Queen’s University, Kingston, Canada
Search for other papers by Charles Chu in
Google Scholar
PubMed
Search for other papers by Charles Chu in
Google Scholar
PubMed
Edmond Y W Chan
Edmond Y W Chan
Department of Biomedical and Medical Sciences, Queen’s University, Kingston, Canada
Search for other papers by Edmond Y W Chan in
Google Scholar
PubMed
Search for other papers by Edmond Y W Chan in
Google Scholar
PubMed
GTPase, optic atrophy 1 (OPA1) ( Cipolat et al. 2004 ). Due to identification of OPA1 mutations linked to autosomal dominant optic atrophy ( Ban et al. 2010 ), the underlying regulation of this protein has been characterised at genetic, biochemical
Francesca Ruggieri
Francesca Ruggieri
Division of Oncology, Medical University of Graz, Graz, Austria
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Search for other papers by Francesca Ruggieri in
Google Scholar
PubMed
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Search for other papers by Francesca Ruggieri in
Google Scholar
PubMed
Katharina Jonas
Katharina Jonas
Division of Oncology, Medical University of Graz, Graz, Austria
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Search for other papers by Katharina Jonas in
Google Scholar
PubMed
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Search for other papers by Katharina Jonas in
Google Scholar
PubMed
Manuela Ferracin
Manuela Ferracin
Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
Search for other papers by Manuela Ferracin in
Google Scholar
PubMed
Search for other papers by Manuela Ferracin in
Google Scholar
PubMed
Michael Dengler
Michael Dengler
Division of Oncology, Medical University of Graz, Graz, Austria
Search for other papers by Michael Dengler in
Google Scholar
PubMed
Search for other papers by Michael Dengler in
Google Scholar
PubMed
Vanessa Jӓger
Vanessa Jӓger
Division of Oncology, Medical University of Graz, Graz, Austria
Search for other papers by Vanessa Jӓger in
Google Scholar
PubMed
Search for other papers by Vanessa Jӓger in
Google Scholar
PubMed
Martin Pichler
Martin Pichler
Division of Oncology, Medical University of Graz, Graz, Austria
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Department of Hematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany
Translational Oncology, University Hospital of Augsburg, Augsburg, Germany
Search for other papers by Martin Pichler in
Google Scholar
PubMed
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Department of Hematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany
Translational Oncology, University Hospital of Augsburg, Augsburg, Germany
Search for other papers by Martin Pichler in
Google Scholar
PubMed
al. 2015 ). The best-studied metabolic alteration is the so-called aerobic glycolysis or ‘Warburg effect’ – first described by German biochemist Otto Warburg in 1920 ( Warburg et al. 1927 , Potter et al. 2016 ). In contrast to normal cells
